Pagina 3 - I migliori immunologi di Immunologia - TOP-92medici

Biography

Our doctor admits patients aged or older than 14.

Medical Education

School of Medicine, 19 Mayıs University

Medical Residency

Infectious Diseases Clinic, Atatürk Teaching and Research Hospital, Izmir

Areas of Interest

Differential diagnosis of fever

Viral hepatitis

Intensive Care Unit Infections

Diabetic Foot

Treatment Methods

• Antibiotherapy
•  
• Antifungal Treatment
•  
• Antiparasitic Treatment
•  
• Antiviral Therapy

Experience

• IZMIR ATATURK TRAINING AND RESEARCH HOSPITAL INFECTIOUS DISEASES CLINIC

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Education and Expertise

• MARMARA UNIVERSITY FACULTY OF MEDICINE

Diseases

• Allergic Rhinitis
• Atopic Dermatitis
• Immune System Diseases
• Asthma in Children
• Food Allergies in Children
• Drug Allergy in Children
• Chronic Cough

Experience

• Hacettepe University Faculty of Medicine
• Dokuz Eylul University Faculty of Medicine

Professional Memberships

• Turkish National Association of Allergy and Clinical Immunology
• European Society of Allergy and Clinical Immunology
• Pediatric Allergy and Asthma Academy Association
• Turkish Thoracic Society
• Pediatric Specialist Academy Association

Education and Specialization

HACETTEPE UNIVERSITY FACULTY OF MEDICINE

HACETTEPE UNIVERSITY FACULTY OF MEDICINE INTERNAL MEDICINE DIVISION

ANKARA UNIVERSITY FACULTY OF MEDICINE ALLERGY AND IMMUNOLOGY DIVISION

Experience

2014 - Hacettepe University Hospitals – Internal Medicine Chief Resident

2019 - 2020 Ankara City Hospital – Compulsory Service

2020 - 2022 Şanlıurfa Training and Research Hospital – Compulsory Service

2023 - İzmir University of Economics Medical Point Hospital Allergy and Immunology Clinic

Professional Memberships

Turkish National Allergy and Clinical Immunology Association

İzmir Medical Chamber

Research Publications

Ünsal P, Çerçi P, Açıkgöz ŞA, Keskin G, Ölmez Ü. Serum Levels of Interleukin-36 Receptor Antagonist in Behçet's Patients. Arthritis Rheumatol. 2017. 69(p10).

Gümüşburun R, Görgülü B, Açıkgöz ŞA, Aydın Ö, Çelik GE, Bavbek S. Succesful Rapid Drug Desensitization to Ferric Carboxymaltose in Four Patients. Asthma Allergy Immunology, 2020. 18(01): 47-50.

Ünsal P, Çerçi P, Açıkgöz ŞA, Keskin G, Ölmez Ü. Serum Levels of Interleukin-36 Alpha and Interleukin-36 Receptor Antagonist in Behcet’s Syndrome. Aktuelle Rheumatologie, 2022. 47(03): 233-8.

Oral presentation

Özbek E, Erkoç M, Çolak S, Açıkgöz ŞA, Ölmez Ü, Keskin G. Evaluation of Cardiopulmonary Status in Patients with Common Variable Immunodeficiency. 28th National Allergy and Clinical Immunology Congress, Antalya, 2021 (SS-26)

Açıkgöz ŞA, Erkoç M. Coronavirus Vaccine Attitudes of Hereditary Angioedema Patients in Şanlıurfa Province. 2nd Çukurova Internal Medicine Days, Adana, 2023 (S-369)

Poster presentation

Çolak S, Çerçi P, Açıkgöz ŞA, Yalçıner M, Keskin G, Ölmez Ü. Evaluation of Cases Who Underwent Allergy Testing for Radiocontrast Material. 23rd National Allergy and Clinical Immunology Congress, Bodrum, 2016 (P-080)

Yalçıner M, Çerçi P, Çolak S, Açıkgöz ŞA, Ölmez Ü, Keskin G. Evaluation of Skin Tests Performed with General Anesthetic Agents and Results of Patients Who Underwent Intervention. 23. National Allergy and Clinical Immunology Congress, Bodrum, 2016 (P-081)

Açıkgöz ŞA, Çerçi P, Çolak S, Yalçıner M, Keskin G, Ölmez Ü. How Necessary is Allergy Testing with Local Anesthetic Agents in Patients Describing Drug Allergy? 23. National Allergy and Clinical Immunology Congress, Bodrum, 2016 (P-082)

Çolak S, Çerçi P, Açıkgöz ŞA, Erol C, Keskin G, Ölmez Ü. Hazelnut Allergy with Clinical Symptoms After Organophosphate Exposure at the Age of 70. 23. National Allergy and Clinical Immunology Congress, Bodrum, 2016 (P-123)

Ünsal P, Çerçi P, Açıkgöz ŞA, Keskin G, Ölmez Ü. Serum Levels of Interleukin-36 Receptor Antagonist in Behçet's Patients. ACR/ARHP Annual Meeting, San Diego, CA, 2017 (Abstract Number: 2728)

Şahin D, Kalacı E, Açıkgöz ŞA, Çolak S, Ölmez Ü, Keskin G. Macrophage Activation Syndrome Developing in Follow-up with ADA-2 Deficiency and Response to Anti-TNF Treatment: Case Report. 18th National Rheumatology Congress, Antalya, 2017 (PS-011)

Köroğlu EY, Açıkgöz ŞA, Çerçi P, Ölmez Ü, Keskin G. A Different Case in Internal Medicine Practice: Diagnosis After 25 Years. 19th National Internal Medicine Congress, Antalya, 2017 (PS-275)

Bilgiç E, Açıkgöz ŞA, Keskin G, Ölmez Ü. Chronic Urticaria Associated with Parasitosis: Two Case Series. 24th National Allergy and Clinical Immunology Congress, Antalya, 2017 (P-190)

Çerçi P, Özbek E, Açıkgöz A, Altıner S, Ölmez Ü, Keskin G. The Story of Two Sisters: Could It Be a Genetic Disease Not Yet Identified? 4th Clinical Immunology Congress, Antalya, 2018 (PS-030)

Gümüşburun R, Görgülü B, Açıkgöz ŞA, Aydın Ö, Çelik GE, Bavbek S. Iron Desensitization; With Four Cases. 25th National Allergy and Clinical Immunology Congress, Antalya, 2018 (P-154)

Çolak S, Özbek E, Açıkgöz A, Erkoç M. A Common Variable Immunodeficiency Case Misdiagnosed as Lymphoma. 25th National Allergy and Clinical Immunology Congress, Antalya, 2018 (P-188)

Dr. Alireza Soltanzadeh, born in Iran in 1969, is an esteemed anesthesiology and reanimation specialist with over 25 years of experience in critical care, cardiac anesthesia, and algology. After graduating from Urmia University of Medical Sciences in 1995, he quickly specialized in anesthesiology and critical care, beginning his practice abroad in 1998. Furthering his expertise, he completed a fellowship in cardiac anesthesia at Istanbul’s Çapa Medical Faculty and the Siyami Ersek Cardiovascular Center in 2006 and trained in pain management (algology) in 2013. His extensive knowledge in these fields makes him a vital asset to the medical community.

Dr. Soltanzadeh has held pivotal roles throughout his career, including a five-year tenure as Chief Physician at a state hospital in Iran. He has enriched his medical education by completing specialized courses in Germany and continues to be an active member of numerous international anesthesiology and medical societies. Since 2018, he has practiced in Istanbul, contributing his expertise to the private sector and currently serves in the Department of Anesthesiology and Reanimation at Istanbul Okan University Hospital.

Fluent in multiple languages, including English, Farsi, Turkish, Azeri, Kurdish, German, and Arabic, Dr. Soltanzadeh’s professional interests extend to ozone therapy, digital medical device innovation, and enhanced patient safety during anesthesia. His research contributions are recognized internationally, with numerous publications and presentations at renowned anesthesia and pain management congresses worldwide. Dr. Soltanzadeh remains committed to advancing medical standards in his field and continuously expanding his clinical and research expertise.

Doctor of Osteopathy from National University of Medical Sciences – Registration S1702131.

Bachelor of science in Osteopathy from National University of Medical Sciences – Registration S1702131.

Certified from “Union of Thai Traditional Medicine Society” – Registration 112460.

Acupuncturist – Certified by Chinese Republic and signed by Notary – Registration 140013.

Member of the International Osteopathic Association (IOA).

Official representative of Osteopathy Chronic Pain Clinics of Canada (OCPCC) in Phuket – Thailand.

Gonstead Chiropractic techniques (inc Knee chest table).

Diploma in Osteopathic & Chiropractic full course online.

Certified Emergency first responder + CPR & AED (valid until 12/2026)

Member of the Swiss Medical Register (RME) – Registration B330879.

Member of the Association of Swiss Health Insurances - Registration 6178.

Certified in Chinese Pharmacology.

Certified in Chinese Psychiatric.

Certified in Chinese Nutrition.

Dr. Gorpong Koowattanataworn, MD, is board-certified in Anti-Aging & Regenerative Medicine (A4M/ABAARM). He earned his MD from the Faculty of Medicine, Ramathibodi Hospital, Mahidol University. He holds a Master’s in Management in Health and Preventive Medicine from Mahidol University. He also holds a Master’s in Anti-Aging & Regenerative Medicine from Mae Fah Luang University. He has a Diploma in Occupational Medicine from Burapha University. He is certified in Practical Stem Cell Therapy (Thai Association of Cell Therapy) and in Chelation Therapy.

Specialties: anti-aging and regenerative medicine; preventive and lifestyle medicine; aesthetic dermatology; cell and stem-cell therapies (MSCs for knee restoration, exosome/MSC therapies); hormone management and bioidentical HRT; cancer immunotherapy (NK cell boosters); weight management; personalized compounded supplements; gut and immune health; men’s sexual health; chelation therapy.

 Mali interdisciplinary hospital is integrating conventional, regenerative and precision medicine. It divides into 11 departments, there are 35 beds in total, including 12 intensive care beds, 23 general beds, 2 emergency and operating rooms, 1 plastic surgical room, 1 Gastro-colonoscopic room. Focus on round-trip treatment with modern medical technology to reduce the cost of hospitalization and the healing time. It also integrating regenerative medicine to repair the body and precision medicine for preventing and treating chronic non-communicable diseases (NCDs) with better results, we provide these services in a greenery atmosphere. Allowing clients to receive the following benefits.

1. Far away from NCDs & It’s complication

2. Good quality of life

3. Youthful lively life

4. Longevity

Il medico dirige il Centro di Melanoma e Immunoterapia del Cancro presso il Centro Medico Hadassah, concentrandosi sulla ricerca innovativa e sul trattamento dei pazienti. Specializzandosi nello studio della famiglia dei recettori SLAM, il medico è in prima linea nella ricerca sulla risposta immunitaria anti-cancro.<\/p>

Coinvolto nel trattamento dei pazienti con melanoma con nuove immunoterapie, il medico lavora con un team di clinici e ricercatori. Questa collaborazione fornisce accesso immediato ai dati clinici e ai tessuti derivati dai pazienti, migliorando gli sforzi di ricerca traslazionale.<\/p>

Il medico è capo del Dipartimento di Ematologia presso l'Hadassah Medical Center e professore specializzato in diagnostica molecolare delle malattie ematologiche, malattie del sangue maligne, trapianto di midollo osseo, terapia genica e immunologia. Dopo essersi laureato presso la Facoltà di Medicina dell'Università Ben-Gurion del Negev, il medico ha completato studi post-laurea presso il Memorial Sloan-Kettering Cancer Center. Nel 2017, il medico è diventato la prima donna a servire come Decano della Scuola di Medicina Hadassah. Il medico è membro di diverse società professionali, tra cui la Società Israeliana di Ematologia e la Società Internazionale di Emato-Oncologia.<\/p>

Dr. Mustafa Emiroglu is a general surgery specialist at Memorial Bodrum Hospital. He has significant experience from his work at Sağlık Bilimleri University Tepecik SUAM (2016–2023) and Kırşehir Hospital (1997–1999).

He earned his medical degree from Istanbul University Cerrahpaşa Faculty of Medicine. He completed his specialization at Tepecik Training and Research Hospital. Dr. Emiroglu is a member of the Turkish Society of Surgery, the Endocrine Surgery Association, and the Colorectal Surgery Association.

He has attended advanced courses, including the Europe Senology Academia. He has also received training in proctologic, hemorrhoidal, and oncoplastic breast surgery, as well as thyroid diseases.

2002 – 2008 – Siriraj Medical School, Mahidol University

2008 – 2013 – Department of Internal Medicine, Rajavithi Hospital

2013 – 2015 – Department of Cardiology, Internal Medicine Rajavithi Hospital

2019 – 2020 – Cardiology Intervention, Department of Cardiology, Internal Medicine Rajavithi Hospital

Languages: English and Thai

September 2022 – September 2023: Metabolic Terrain Institute of Health (USA)
2021 – 2023: American Institute of Integrative Oncology
February – May 2019: Swiss Biological Medicine Academy (Switzerland), Education Module 1-6
May 2015: Gerson Institute (USA, California), Gerson Practitioner Training Program, Module 1
2010 – 2013: Riga Gestalt Institute, Psychotherapy (Gestalt Therapy) Studies, Certified Gestalt Practitioner

These experiences reflect a broad and specialized background in integrative oncology, biological medicine, and psychotherapy.

• Wang He Tian
• Head of the Department of Traditional Chinese Medicine
• Executive Director of the Beijing Association of Traditional Chinese Medicine
• Deputy Director of the Working Committee on the Inheritance and Development of Chinese Medicine, Chinese Medical Association
• Deputy Director of the Professional Committee of Chinese Medicine, Chinese Geriatric Society
• Secretary General of the Geriatric Committee of the Beijing Association of Traditional Chinese Medicine
• Permanent Member of the Professional Andrology Committee of Beijing Association of Integrative Traditional Chinese and Western Medicine
• Executive Director of the Andrology Department of the Society of Traditional Chinese Medicine
• Director of Beijing Medical Preventive Association
• Leading expert of the Beijing Group of Experts on Chinese Medicine
• Beijing's leading expert on traditional Chinese medicine and inheritance of academic experience
• Achievement Assessment Expert of the State Administration of Traditional Chinese Medicine
• Medical Director of Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
• Author and co-author of more than 10 clinical books on traditional Chinese medicine.
• Winner of the Beijing Science and Technology Commission Award for Scientific and Technological Progress in Clinical Research
• Deputy Director of the Department of Medical Affairs of Beijing Municipal Administration of Traditional Chinese Medicine

Achieved outstanding success in the treatment of the following pathologies:

• chronic inflammatory processes
• chronic dystrophic-degenerative processes
• diseases of the digestive system
• diseases of the spleen
• kidney disease
• prostate diseases
• sexual dysfunction
• female infertility
• urological diseases
• andrological diseases
• pathological processes accompanied by circulatory disorders and blood stagnation
• bedsores
• spinal diseases
• complex clinical cases
• intractable diseases
• rehabilitation treatment

Dr. Luis Padilla is a physician who specializes in gynecologic oncology, general practice, and healthcare administration. He helped introduce the da Vinci Robotic Assisted Surgical System, which improved minimally invasive surgery.

Dr. Padilla has worked as Associate Administrator for Health Workforce at HRSA. He also served as Director of the NHSC. In these roles, he influenced national health policy and workforce training. He has received the People’s Choice Award and the People Living Through Cancer Award for his commitment to patient care.

He served on the National Advisory Council of the NHSC from 2007 to 2010. He earned degrees from UC Irvine, Wake Forest, Brown, Northwestern, and the University of Minnesota.